Kundalini yoga (KY) has less consistent or robust efficacy compared with cognitive behavioural therapy (CBT) for adults with generalized anxiety disorder (GAD), results of a randomized clinical trial have shown.
“Our study’s results support CBT to remain as first-line treatment for adults with GAD. Future research is needed to better understand individual differences in the heterogenicity of response to KY and CBT,” concluded the researchers. [JAMA Psychiatry 2020, doi: 10.1001/jamapsychiatry.2020.2496]
In the study, 226 participants (mean age, 33.4 years; female, 69.9 percent) with a primary diagnosis of GAD were randomized to receive KY (n=93), CBT (n=90) or stress education (SE; n=43). The interventions were each delivered to groups of 4–6 participants by 2 instructors during twelve 120-minute sessions, with 20 minutes of daily homework.
Post-treatment assessment was completed in 68.1 percent of all patients, without any significant difference in completion rates across treatments (KY, 64.5 percent; CBT, 74.4 percent; SE, 65.1 percent; p=0.30). Participants who dropped out tended to be younger compared with participants who completed the study (31.1 years vs 35.7 years; p=0.07).
Response rates, assessed by Clinical Global Impression-Improvement (CGI-I) Scale score of 1 or 2 (ie, much improved or very much improved), at the post-treatment assessment were significantly higher with KY vs SE (54.2 percent vs 33.0 percent; odds ratio [OR], 2.46; 95 percent confidence interval [CI], 1.12 to 5.42; p=0.03; number needed to treat [NNT], 4.59) and in the CBT group vs the SE group (70.8 percent vs 33.0 percent; OR, 5.00; 95 percent CI, 2.12 to 11.82; p<0.001; NNT, 2.62). The noninferiority test did not find KY to be as effective as CBT (difference, 16.6 percent; p=0.42 for noninferiority).
At 6-month follow-up, response rates remained higher with CBT vs SE (76.7 percent vs 48.0 percent; OR, 3.56; 95 percent 1.08 to 11.70; p=0.04; NNT, 3.51), and were similar between the KY and SE groups (63.2 percent vs 48.0 percent; OR, 1.86; 95 percent CI, 0.52 to 6.69; p=0.34).
Neither differences in rates of depression at baseline (25.6 percent vs 12.9 percent) nor medication use during follow-up (24.4 percent vs 3.2 percent) accounted for the differences between the CBT group and the KY group, or moderated outcomes at the post-treatment or follow-up assessment.